Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
starting as soon as possible. Position Description: The position is funded by an Interdisciplinary Synergy Grant from the Novo Nordisk Foundation for the project BioNWire. The project aims to self-assemble a
-
creative working environment. You will be integrated in a very creative research team which is focusing on the first large scale universal optical quantum computing under in the Novo Nordisk Quantum
-
working with newborn infants, neonatal mice and preterm lambs. Project description This PhD position will be a part of a project funded by the Novo Nordisk Foundation within Basic Bioscience and Biomedicine
-
collaboration. The Novo Nordisk Foundation Center for Biosustainability (DTU Biosustain) Recent progress in our ability to read and write genomic code, combined with advances in automation, analytics and data
-
towards scientific innovation and excellence through thoughtful and responsible science, communication and collaboration. The Novo Nordisk Foundation Center for Biosustainability (DTU Biosustain) Recent
-
, Denmark Posted on 01/25/2024 The Novo Nordisk Foundation for Biosustainability (DTU Biosustain) at the Technical University of Denmark is seeking highly motivated PhD candidates with an interest in deep
-
questions about glycolysis based on the results. These projects are funded by a Novo Nordisk Foundation Laureate grant. Responsibilities and qualifications You will work as part of a team to improve the
-
Postdoc in statistics to develop Bayesian privacy metrics for synthetic health data (2024-224-05725)
scientist, students, and a student helper. The project is a part of the ambitious Novo Nordisk Foundation Data Science Collaborative Programme,“Synthetic health data: ethical development and deployment via
-
part of the Novo Nordisk Foundation Center for Biosustainability. We develop novel yeast cell factories to produce chemicals and natural products in a more sustainable way. We have supportive and
-
), The Novo Nordisk Foundation Center for Stem Cell Medicine (renew) at University of Copenhagen, and Bioneer A/S that aims at developing new in vitro disease models and cell therapies using human induced